Stanford Cancer Institute Innovation Awards
Stanford University's Cancer Institute Innovation Awards fund collaborative, cutting-edge cancer research to advance prevention, diagnosis, and treatment by translating discoveries into improved patient outcomes.
Funder: Stanford University
Due Dates: October 15, 2026 (Full application deadline)
Funding Amounts: $75,000 per project for up to 12 months
Summary: Supports innovative, collaborative cancer research projects at Stanford, advancing prevention, diagnosis, and treatment.
Key Information: PI eligibility is limited to Academic Council or University Medical Line faculty; postdocs/instructors may only participate as collaborators.
Description
The Stanford Cancer Institute (SCI) Innovation Awards are designed to accelerate progress in cancer research by supporting pioneering projects that foster interdisciplinary collaboration and innovative approaches across basic, translational, clinical, and population-based research. The program prioritizes initiatives that translate scientific discoveries into clinical applications, develop investigator-initiated clinical trials, create new technologies (e.g., non-viral gene delivery), and enhance patient-centered care. The overarching goal is to reduce cancer mortality and improve patient outcomes through research-driven innovation.
